Opinion|Videos|September 9, 2024

Strategies for Prevention and Screening of CRM Conditions

Name: Strategies for Prevention and Screening of CRM Conditions
Uploaded: 2024-09-09T17:27:14.913Z
Duration: AJ7M18S
Description: Strategies for Prevention and Screening of CRM Conditions

Key Takeaways

Integrating early intervention strategies for HF and T2D can prevent CKD, enhancing patient outcomes and reducing disease progression.
Standardized protocols and education are crucial for improving early CKD screening across diverse healthcare settings.
Value-based care models and technology can incentivize healthcare providers to prioritize early screening and intervention for CRM conditions.
Reimbursement models that reward early detection and management can encourage proactive healthcare practices, reducing long-term costs.

Experts in cardiometabolic risk management explore strategies for the prevention and screening of cardiometabolic conditions.

Video content above is prompted by the following:

What does a successful CRM prevention or screening program look like in practice?
Can early intervention in patients with HF or T2D prevent CKD or vice versa?
How can early screening for CKD be improved and effectively implemented across different healthcare settings?
What specific steps can healthcare providers take to incentivize early screening and intervention for CRM conditions?
How can payers structure their reimbursement models to incentivize early detection and management of conditions like CKD, HF, and T2D?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Strategies for Prevention and Screening of CRM Conditions

Key Takeaways

Newsletter

Related Content

Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color

Stronger Primary Care, Oncology Partnerships May Improve Patient Outcomes: Mark Fendrick, MD

Trust, Data Transparency Needed to Strengthen Payer-Provider Collaboration in Oncology: Vishnukamal Golla, MD, MPH

Colon Cancer Recurrence Risk Nearly Gone After 6 Years, Study Reveals

Understanding Gaps and Limitations in Current ITP Therapies

Latest CME

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Overview and Burden of Migraine

The Role of the Pharmacist Migraine Management

The Evolving Treatment Landscape of Migraine

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

Trending on AJMC

Withdrawal of Aid Could Cause Millions of Lives Lost to HIV

EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy

Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color

Mortality Gap Between Puerto Rico and the US Mainland Among Medicare Advantage Enrollees

FDA Approves Second Generic Mifepristone Pill for Abortion